Version: 1.1.5037.23448-7fe1cda529b97ebc52da0f2bbefb0d41deb9638a

Item was added to the Sample Submission form

Item was added to the Quote Request form

Systemic Toxicity Test

Systemic Toxicity Test

The Biocompatibility Acute Systemic Toxicity test evaluates the potential adverse effects of a medical device on the body’s organs and tissues that are remote from the site of contact. Depending on the type of device being tested, the following applications may be observed for toxicity: topical, inhalation, intravenous, intra peritoneal or oral administration of extracts, or implantation of the device in the animal. This test is performed on any device that would contact the interior of a patient’s body and complies with ISO 10993-11.

Download the biocompatibility test matrix. [Based on ISO 10993-1:2010 (E) and FDA G95-1 Guidelines]

Applicable Standards

  • ISO 10993

Test Options

Standard turn around times (TAT) are listed below. Ask an expert for a specific consultation on your product.

Code Test TAT (days) Request Quote
SCX305 Systemic Toxicity: Systemic Injection (USP), 2 extracts Add
SCX306 Systemic Toxicity (GLP): Systemic Injection (USP), 2 extracts Add
SCX310 Systemic Toxicity: Systemic Injection (ISO), 2 extracts Add
SCX311 Systemic Toxicity (GLP): Systemic Injection (ISO), 2 extracts Add
SCX315 Systemic Toxicity: Systemic Injection (ISO), liquid/chemical Add
SCX316 Systemic Toxicity (GLP): Systemic Injection (ISO), liquid/chemical Add
SCX320 Systemic Toxicity: Material Mediated Pyrogen, each Add
SCX321 Systemic Toxicity (GLP): Material Mediated Pyrogen, each Add
SCX305 - Systemic Toxicity: Systemic Injection (USP), 2 extracts
Standard TAT not available for this product
SCX306 - Systemic Toxicity (GLP): Systemic Injection (USP), 2 extracts
Standard TAT not available for this product
SCX310 - Systemic Toxicity: Systemic Injection (ISO), 2 extracts
Standard TAT not available for this product
SCX311 - Systemic Toxicity (GLP): Systemic Injection (ISO), 2 extracts
Standard TAT not available for this product
SCX315 - Systemic Toxicity: Systemic Injection (ISO), liquid/chemical
Standard TAT not available for this product
SCX316 - Systemic Toxicity (GLP): Systemic Injection (ISO), liquid/chemical
Standard TAT not available for this product
SCX320 - Systemic Toxicity: Material Mediated Pyrogen, each
Standard TAT not available for this product
SCX321 - Systemic Toxicity (GLP): Material Mediated Pyrogen, each
Standard TAT not available for this product

Sample Specifications

SCX305: Turn Around Time is 35 days from PDS approval. 2 complete devices, each device must be 120 cm2 or 4 grams.
SCX306: Turn Around Time is 35 days from PDS approval. 2 complete devices, each device must be 120 cm2 or 4 grams.
SCX310: Turn Around Time is 35 days from PDS approval. 2 complete devices, each device must be 120 cm2 or 4 grams.
SCX311: Turn Around Time is 35 days from PDS approval. 2 complete devices, each device must be 120 cm2 or 4 grams.
SCX315: Turn Around Time is 28 days from PDS approval. 10 mL.
SCX316: Turn Around Time is 28 days from PDS approval. 10mL.
SCX320: Turn Around Time is 35 days from PDS approval. 900 cm2 or 30 grams.
SCX321: Turn Around Time is 35 days from PDS approval. 900 cm2 or 30 grams.

Study Outline

In the Biocompatibility Systemic Toxicity test, mice are injected intraperitoneally or intravenously with either extracts or solutions of the test article or control (vehicle without test article). The animals will be observed for signs of toxicity immediately after injection and at 4 ± 0.75, 24 ± 2, 48 ± 2 and 72 ± 2 hours post-injection. Body weights will be measured prior to injection and on all three subsequent days.